Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

BACKGROUND: Empagliflozin has been reported to protect endothelial cell function, regardless of diabetes status. However, the role of empagliflozin in microvascular protection during myocardial ischemia reperfusion injury (I/R) has not been fully understood. METHODS: Electron microscopy, western blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Rongjun, Shi, Wanting, Qiu, Junxiong, Zhou, Na, Du, Na, Zhou, Hao, Chen, Xinxin, Ma, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202214/
https://www.ncbi.nlm.nih.gov/pubmed/35705980
http://dx.doi.org/10.1186/s12933-022-01532-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202214/
https://www.ncbi.nlm.nih.gov/pubmed/35705980
http://dx.doi.org/10.1186/s12933-022-01532-6

Ejemplares similares